Correlation Between Vaccinex and Xilio Development
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Xilio Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Xilio Development into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Xilio Development, you can compare the effects of market volatilities on Vaccinex and Xilio Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Xilio Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Xilio Development.
Diversification Opportunities for Vaccinex and Xilio Development
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Vaccinex and Xilio is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Xilio Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xilio Development and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Xilio Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xilio Development has no effect on the direction of Vaccinex i.e., Vaccinex and Xilio Development go up and down completely randomly.
Pair Corralation between Vaccinex and Xilio Development
If you would invest 72.00 in Xilio Development on November 27, 2024 and sell it today you would earn a total of 22.00 from holding Xilio Development or generate 30.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Vaccinex vs. Xilio Development
Performance |
| Timeline |
| Vaccinex |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Xilio Development |
Vaccinex and Xilio Development Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaccinex and Xilio Development
The main advantage of trading using opposite Vaccinex and Xilio Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Xilio Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will offset losses from the drop in Xilio Development's long position.| Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
| Xilio Development vs. Connect Biopharma Holdings | Xilio Development vs. Tyra Biosciences | Xilio Development vs. RAPT Therapeutics | Xilio Development vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |